253 related articles for article (PubMed ID: 21595558)
1. Follicular thyroid carcinoma with metastases to the pituitary causing pituitary insufficiency.
Vianello F; Mazzarotto R; Taccaliti A; Lora O; Basso M; Servodio O; Mian C; Sotti G
Thyroid; 2011 Aug; 21(8):921-5. PubMed ID: 21595558
[TBL] [Abstract][Full Text] [Related]
2. Pituitary metastases from follicular thyroid carcinoma.
Prodam F; Pagano L; Belcastro S; Golisano G; Busti A; Samà M; Caputo M; Bellone S; Voci A; Valente G; Aimaretti G
Thyroid; 2010 Jul; 20(7):823-30. PubMed ID: 20604687
[TBL] [Abstract][Full Text] [Related]
3. Papillary thyroid carcinoma metastatic to the pituitary gland.
Masiukiewicz US; Nakchbandi IA; Stewart AF; Inzucchi SE
Thyroid; 1999 Oct; 9(10):1023-7. PubMed ID: 10560958
[TBL] [Abstract][Full Text] [Related]
4. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
5. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.
Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F
Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of differentiated thyroid carcinoma.
Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: preliminary therapeutic experience.
Perros P
J Endocrinol Invest; 1999; 22(11 Suppl):30-4. PubMed ID: 10727003
[TBL] [Abstract][Full Text] [Related]
8. Pituitary metastasis of follicular thyroid carcinoma.
Chrisoulidou A; Pazaitou-Panayiotou K; Flaris N; Drimonitis A; Giavroglou I; Ginikopoulou E; Vainas I
Horm Res; 2004; 61(4):190-2. PubMed ID: 14739527
[TBL] [Abstract][Full Text] [Related]
9. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
Dottorini ME; Vignati A; Mazzucchelli L; Lomuscio G; Colombo L
J Nucl Med; 1997 May; 38(5):669-75. PubMed ID: 9170425
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
Lind P; Igerc I; Kohlfürst S
Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
[TBL] [Abstract][Full Text] [Related]
11. Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer.
Santarpia L; Gagel RF; Sherman SI; Sarlis NJ; Evans DB; Hoff AO
Head Neck; 2009 Mar; 31(3):419-23. PubMed ID: 18798312
[TBL] [Abstract][Full Text] [Related]
12. Recombinant thyroid-stimulating hormone in differentiated thyroid cancer.
Krausz Y; Uziely B; Nesher R; Chisin R; Glaser B
Isr Med Assoc J; 2001 Nov; 3(11):843-9. PubMed ID: 11729583
[TBL] [Abstract][Full Text] [Related]
13. Medullary thyroid carcinoma metastatic to the pituitary gland: an unusual site of metastasis.
Williams MD; Asa SL; Fuller GN
Ann Diagn Pathol; 2008 Jun; 12(3):199-203. PubMed ID: 18486896
[TBL] [Abstract][Full Text] [Related]
14. Hypopituitarism caused by pituitary metastasis of supraglottic laryngeal carcinoma: case report.
Kruljac I; Sulentić P; Cigrovski-Berković M; Petrović V; Pećina HI; Cerina V; Houra K; Pazanin L; Vrkljan M
Acta Clin Croat; 2010 Sep; 49(3):347-51. PubMed ID: 21462828
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarism.
Ringel MD; Ladenson PW
J Clin Endocrinol Metab; 1996 May; 81(5):1724-5. PubMed ID: 8626823
[TBL] [Abstract][Full Text] [Related]
16. Thyroid remnant dose: 124I-PET/CT dosimetric comparison of rhTSH versus thyroid hormone withholding before radioiodine remnant ablation in differentiated thyroid cancer.
Freudenberg LS; Frömke C; Petrich T; Marlowe RJ; Koska WW; Brandau W; Eising EG; Knust EJ; Bockisch A; Jentzen W
Exp Clin Endocrinol Diabetes; 2010 Jul; 118(7):393-9. PubMed ID: 19856257
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human TSH in radioiodine treatment of differentiated thyroid cancer.
Kovatcheva RD; Hadjieva TD; Kirilov GG; Lozanov BS
Nucl Med Rev Cent East Eur; 2004; 7(1):13-9. PubMed ID: 15318305
[TBL] [Abstract][Full Text] [Related]
18. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
[TBL] [Abstract][Full Text] [Related]
19. The role of recombinant thyroid-stimulating hormone (rhTSH) in the detection and management of well-differentiated thyroid carcinoma: a roundtable discussion.
Schlumberger MJ; Incerti C; Pacini F; Reiners C
J Endocrinol Invest; 1999; 22(11 Suppl):35-41. PubMed ID: 10727004
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human TSH increases uptake and effective half-life of radioiodine in thyroid hormone secreting metastases of follicular thyroid cancer.
Schneider C; Dietlein M; Eschner W; Schmidt M; Kahraman D; Kobe C
Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):160-3. PubMed ID: 22328109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
